Loading...
Loading...
Cothera Bioscience Patents
Cothera Bioscience has filed 4 patents.
The 3 most popular patent topics include:
- fluoroarenes
- indoles
- cannabinoids
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/8/2019 | 9/12/2023 | Indoles, Tyrosine kinase receptors, Transcription factors, Experimental cancer drugs, Fluoroarenes | Grant |
Application Date | 4/8/2019 |
|---|---|
Grant Date | 9/12/2023 |
Title | |
Related Topics | Indoles, Tyrosine kinase receptors, Transcription factors, Experimental cancer drugs, Fluoroarenes |
Status | Grant |
Latest Cothera Bioscience News
Oct 6, 2021
Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"
Cothera Bioscience Frequently Asked Questions (FAQ)
When was Cothera Bioscience founded?
Cothera Bioscience was founded in 2012.
Where is Cothera Bioscience's headquarters?
Cothera Bioscience's headquarters is located at Hangzhou.
What is Cothera Bioscience's latest funding round?
Cothera Bioscience's latest funding round is Series B.
How much did Cothera Bioscience raise?
Cothera Bioscience raised a total of $30M.
Who are the investors of Cothera Bioscience?
Investors of Cothera Bioscience include Harbinger Venture Capital, CMB International Capital, Kunlun Fund, Sherpa Venture Capital, New World Investment and 6 more.
Loading...
Loading...